RalA/ single-cell resolution, normal hematopoietic stem cell, leukemia stem cell, imatinib resistance, gene editing mouse
phenylketonuria (PKU), phenylalanine hydroxylase (PAH), mRNA technology, self-amplifying mRNA, Lipid Nanoparticle (LNP), replacement therapy